Individual Article: Brodalumab Is an Efficacious, Safe, and Cost-Effective IL-17 Receptor Blocker for the Treatment of Moderate-to-Severe Plaque Psoriasis: 2023 Update
October 2023 | Volume 22 | Issue 10 | SF378632s5 | Copyright © October 2023
Published online September 29, 2023
Naiem T. Issa MD PhDa,b, Leon Kircik MDc
aForefront Dermatology, Vienna, VA
bIssa Research & Consulting, LLC, Springfield, VA
cIcahn School of Medicine at Mount Sinai, New York, NY; Physicians Skin Care, PLLC, Louisville, KY; DermResearch, PLLC, Louisville, KY; Skin Sciences, PLLC, Louisville, KY
